New Studies for Patient with Relapsed, CD30-Positive Lymphoma - 100038


New Studies for Patient with Relapsed, CD30-Positive Lymphoma

patientpower has 2417 videos Subscribe Here

Description: Recorded at the 2014 International Workshop on Non-Hodgkin Lymphoma, Dr. Owen O’Connor gives an update on brentuximab vedotin (Adcetris), an antibody drug conjugate (ADC) approved for the treatment of CD30-positive lymphomas, like anaplastic large-cell lymphoma and Hodgkin lymphoma. Dr. O’Connor explains clinical trials using this drug in new ways, studying whether it can be used to target CD30 in other diagnoses and how combining it with other modes of therapies may make it an even more effective therapy.

Read the transcript | http://www.patientpower.inf...

Dr. Owen O’Connor is a hematology/oncologist who leads the oncology program New York University’s (NYU) Langone Medical Center.

View more programs with Dr. O'Connor | http://www.patientpower.inf...

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Follow on Google+ |
Shared By : patientpower
Posted on : 09/26/14
Added : 3 years ago
Category : Lymphoma